Justin Loke

1.8k total citations
25 papers, 1.0k citations indexed

About

Justin Loke is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Justin Loke has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Justin Loke's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Epigenetics and DNA Methylation (3 papers). Justin Loke is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Epigenetics and DNA Methylation (3 papers). Justin Loke collaborates with scholars based in United Kingdom, United States and Netherlands. Justin Loke's co-authors include Charles Craddock, Ram Malladi, Paul Moss, Manoj Raghavan, Mike Griffiths, Richard J. Buka, Charles Crawley, Shamyla Siddique, Jane Nunnick and Gordon B. Ryan and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Justin Loke

25 papers receiving 988 citations

Peers

Justin Loke
Marta Sánchez-Martín United States
André Haman Canada
T Hoang Canada
Jesús Duque‐Afonso Germany
Linda B. Baughn United States
Dorothy J. Park United States
Jette Ford Australia
Ricardo López‐Pérez Spain
Marina Lanciotti Italy
Anita Ryningen Norway
Marta Sánchez-Martín United States
Justin Loke
Citations per year, relative to Justin Loke Justin Loke (= 1×) peers Marta Sánchez-Martín

Countries citing papers authored by Justin Loke

Since Specialization
Citations

This map shows the geographic impact of Justin Loke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Loke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Loke more than expected).

Fields of papers citing papers by Justin Loke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Loke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Loke. The network helps show where Justin Loke may publish in the future.

Co-authorship network of co-authors of Justin Loke

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Loke. A scholar is included among the top collaborators of Justin Loke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Loke. Justin Loke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loke, Justin, Peter G. Kim, Thuy T. P. Nguyen, et al.. (2025). An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis. Blood. 146(10). 1174–1186. 2 indexed citations
2.
Kinsella, Francesca, et al.. (2024). Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia. British Journal of Haematology. 204(6). 2173–2183. 1 indexed citations
3.
Loke, Justin, Aimee Jackson, Shamyla Siddique, et al.. (2023). Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS. Blood Advances. 7(14). 3666–3676. 21 indexed citations
4.
Loke, Justin, Myriam Labopin, Charles Craddock, et al.. (2022). Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia. Cancer. 128(15). 2922–2931. 31 indexed citations
5.
Loke, Justin, Marlen Metzner, Rebecca H. Boucher, et al.. (2021). Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology. 196(2). 368–373. 3 indexed citations
6.
O’Connor, Dominic, Justin Loke, Malcolm Brown, et al.. (2021). Non‐pharmacological supportive‐care interventions in acute myeloid leukaemia: a review of randomised controlled trials. British Journal of Haematology. 195(1). e97–e113. 2 indexed citations
7.
Loke, Justin, Richard J. Buka, & Charles Craddock. (2021). Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?. Frontiers in Immunology. 12. 659595–659595. 49 indexed citations
8.
Loke, Justin, et al.. (2021). Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia. Frontiers in Oncology. 11. 666091–666091. 12 indexed citations
9.
10.
Loke, Justin, David M. Lowe, Laura Miller, et al.. (2020). Supportive care in the management of patients with acute myeloid leukaemia: where are the research needs?. British Journal of Haematology. 190(3). 311–313. 6 indexed citations
11.
Loke, Justin, Myriam Labopin, Charles Craddock, et al.. (2020). Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone Marrow Transplantation. 56(3). 614–621. 4 indexed citations
12.
Loke, Justin, Paulynn Suyin Chin, Peter Keane, et al.. (2018). C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia. Blood Advances. 2(3). 271–284. 14 indexed citations
13.
Malaker, Stacy A., Sarah Penny, Justin Loke, et al.. (2017). Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia. Cancer Immunology Research. 5(5). 376–384. 109 indexed citations
14.
Loke, Justin, Salam A. Assi, Maria Rosaria Imperato, et al.. (2017). RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML. Cell Reports. 19(8). 1654–1668. 37 indexed citations
15.
Cauchy, Pierre, Sally James, Joaquin Zacarías-Cabeza, et al.. (2015). Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature. Cell Reports. 12(5). 821–836. 48 indexed citations
16.
Mussai, Francis, Sharon A. Egan, Tracey Perry, et al.. (2015). Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood. 125(15). 2386–2396. 126 indexed citations
17.
Loke, Justin, Jamal Nasir Khan, Jayne S. Wilson, Charles Craddock, & Keith Wheatley. (2014). Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia. Annals of Hematology. 94(3). 361–373. 50 indexed citations
18.
Goodyear, Oliver, Mike Dennis, Justin Loke, et al.. (2012). Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood. 119(14). 3361–3369. 301 indexed citations
19.
Wheeler, Daniel W., Andrew J. Thompson, Federico Corletto, et al.. (2011). Anaesthetic Impairment of Immune Function Is Mediated via GABAA Receptors. PLoS ONE. 6(2). e17152–e17152. 57 indexed citations
20.
Hughes, David, Peter J. Friend, Justin Loke, et al.. (2007). Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients. Journal of Clinical Virology. 41(2). 92–95. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Sánchez-Martín Breakdown of academic impact, for papers by André Haman Breakdown of academic impact, for papers by T Hoang Breakdown of academic impact, for papers by Jesús Duque‐Afonso Breakdown of academic impact, for papers by Linda B. Baughn Breakdown of academic impact, for papers by Dorothy J. Park Breakdown of academic impact, for papers by Jette Ford Breakdown of academic impact, for papers by Ricardo López‐Pérez Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by Anita Ryningen
Rankless by CCL
2026